All stock lists
Prothena Corp Public Ltd Co (NASDAQ:PRTA)
IE · Delayed Price · Currency is USD
Healthcare · Biotechnology
8.37+0.17 (+2.07%)
Insider Score
––Not scored
PRTA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
PRTA analyst forecast
PRTA analyst consensus
No analyst ratings in the last 3 months.
PRTA 12-month price target
$28.33+236.5% upsideaverage of 3 firms
$36.00High
$19.00Low
Best analysts covering PRTA
No firm covering PRTA has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
PRTA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| H.C. Wainwright | — | $30.00 | +251.7% | — | 2026-07-24 | |
| JMP Securities | — | $19.00 | +76.7% | — | 2025-12-01 | |
| Piper Sandler | — | $36.00 | +224.8% | — | 2025-10-28 | |
| JMP Securities | — | $11.00 | +33.0% | — | 2025-09-02 | |
| Oppenheimer | — | $62.00 | +213.6% | — | 2024-08-14 | |
| RBC Capital | — | $24.00 | +22.0% | — | 2024-08-09 | |
| RBC Capital | — | $28.00 | +21.6% | — | 2024-05-09 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.